HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Clinical trials for HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) explained in plain language.

Never miss a new study

Get alerted when new HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) trials appear

Sign up with your email to follow new studies for HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Liver function and new drug: a safety check

Knowledge-focused Not yet recruiting

This early-stage study tests a single dose of MDR-001 tablets in 32 people with mild or moderate liver impairment and matched healthy volunteers. The goal is to see how the liver affects drug levels in the blood and to check for any safety issues. Results will guide future dosing…

Matched conditions: HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Phase: PHASE1 • Sponsor: MindRank AI Ltd • Aim: Knowledge-focused

Last updated May 17, 2026 13:59 UTC

HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B)

Get alerted when new HEPATIC IMPAIRMENT (MILD AND MODERATE, CHILD-PUGH CLASS A AND B) trials appear

Liver function and new drug: a safety check